logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hengrui Medicine (01276.HK) spent 3.6684 million yuan to repurchase 60,000 shares of A-shares on November 10th.

date
10/11/2025
Zhtng Cijng APP News, Hansoh Pharmaceutical (01276.HK) announced that on November 10, 2025, the company spent 3.6684 million yuan to repurchase 60,000 shares of A shares, at a repurchase price of 61.00-61.31 yuan per share.
Latest
2 m ago
Don't be scared by short-term fluctuations! Wall Street is sending a "reassurance pill" to the market: corporate profits will support the rise of US stocks next year.
2 m ago
Federal Reserve Daley: An open mindset is needed to formulate the correct policies.
2 m ago
Dali Group Holdings (01921.HK) has officially put into operation a new "intelligent production line for high-end energy equipment tubes," taking a crucial step in intelligent manufacturing and capacity upgrading.
3 m ago
Chengxing Stock: There may be irrational speculation risks in the company's stock price.
3 m ago
XDream Robotics has received tens of millions of yuan in angel funding.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.